Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 crossover MRI contrast study of gadoquatrane vs macrocyclic GBCAs (non-CNS)
CTR20232191Phase 3Completed
- Sponsor
- ---/ 拜耳医药保健有限公司
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadoquatrane in None, sponsored by ---/ 拜耳医药保健有限公司. Started Jul 2023; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on CTR20232191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232191.